Haemophilia A

·MeSH: Hemophilia A

Prevalence

5.0 / 100K

8 drugs in development·2 companies·16 clinical trials

Drug Pipeline by Phase

Phase 3(4)

Phase 1(2)

Drug	Company
nnc0365-3769	Novo Nordisk A/S (NVO)
nnc0442-0344 a	Novo Nordisk A/S (NVO)

Unknown(1)

Drug	Company
esperoct	Novo Nordisk A/S (NVO)

Phase 1/Phase 2(1)

Drug	Company
valoctocogene roxaparvovec	BIOMARIN PHARMACEUTICAL INC (BMRN)

BioSniper tracks 8 drugs in development for Haemophilia A across 2 companies.

There are 16 clinical trials targeting Haemophilia A tracked by BioSniper.

The estimated prevalence of Haemophilia A is approximately 5.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.